Arrhythmia Market Overview, Analysis And Demand By 2034

Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends

What Is the Current Market Size and Growth Rate of the Arrhythmia Market?
The arrhythmia market size has grown strongly in recent years. It will grow from $7.8 billion in 2024 to $8.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased lifestyle-related risk factors, rise in cardiovascular diseases, improvements in implantable devices, global increase in cardiac surgery, growing demand for remote monitoring, research and development in antiarrhythmic drugs.

The arrhythmia market size is expected to see strong growth in the next few years. It will grow to $11.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expanding awareness and education, personalized medicine approaches, expansion of electrophysiology labs, focus on early detection and prevention, genetic screening for familial arrhythmias, healthcare infrastructure development. Major trends in the forecast period include advancements in cardiac monitoring technologies, telehealth and remote patient monitoring, focus on atrial fibrillation (AF) detection and management, implantable devices for arrhythmia management, innovations in ECG monitoring devices, regulatory focus on medical device approvals.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

What Are the Key Drivers of the Arrhythmia Market?
The rising prevalence of cardiac disease and other heart problems is expected to propel the growth of the arrhythmia market going forward. Cardiac disease or cardiovascular disease refers to a collection of heart and blood vessel conditions, including several conditions such as atherosclerosis, heart attack, stroke, and arrhythmia, among others. Both functional defects, including diastolic and systolic dysfunction, and electrical defects, including the development of arrhythmias, can result in a high prevalence of heart failure, atrial fibrillation, and other cardiovascular diseases. For instance, in October 2022, according to the CDC (Centers for Disease Control and Prevention), a US-based government agency, every year in the United States, there were estimated to be 69.7k heart disease-related deaths and 80.5k heart attacks every year. [i] Thus, the rising prevalence of cardiac disease and other heart problems is driving the growth of the arrhythmia market.

How Is the Arrhythmia Market Segmented?
The arrhythmiamarket covered in this report is segmented –

1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes

What Are the Key Trends Shaping the Arrhythmia Market?
New therapies for treatment are a key trend in the arrhythmia market. Major players operating in the market are advancing toward developing new therapies, such as cryoablation therapy, an innovative treatment used in patients with arrhythmias. For instance, in August 2023, GE HealthCare a US-based medical technology company launched CardioVisio for Atrial Fibrillation, a digital, patient-centric clinical decision support tool designed to enable precision care. CardioVisio leverages advanced data analytics and patient insights to help healthcare professionals better understand and manage atrial fibrillation, a common heart condition. By offering personalized care plans and real-time data tracking, this tool aims to enhance the accuracy of treatment decisions and improve patient outcomes, marking a significant step forward in cardiac care management.

Which Are the Top Companies in the Arrhythmia Market?
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA

Get the full arrhythmia market report here:
https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

Which Region Is Projected to Account for the Largest Share of the Arrhythmia Market?
North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company